AKT1 and hepatocellular carcinoma: The activation of the PI3K-Akt (∼70%) and mechanistic target of rapamycin complex 1 (mTORC1) (∼45%) pathways was observed in HCC and demonstrated a positive correlation with tumor metastasis, recurrence and poor prognosis (Chaturantabut et al., 2019).